Emerging viruses
Emerging and re-emerging viral diseases have increased in number and geographical extent during the last decades. Examples include the current COVID-19 pandemic, the recent epidemics of chikungunya, ebola and Zika viruses and the emergence of dengue and other arthropod-borne viruses in non-endemic areas. The main research lines include:
- Evaluation of molecular and serological diagnostic methods for emerging viral infections
- Phylogenetic characterization of dengue and other arboviruses
- Surveillance of arboviral diseases in endemic and non-endemic areas
- Clinical presentation, prophylaxis and treatment of COVID-19
Our Team
Our team
-
Carlos Chaccour Assistant Research Professor. BOHEMIA Chief Scientific Officer -
Carlota Dobaño Research Professor - Alberto García-Basteiro
- Alfredo Mayor Research Professor
-
Clara Menéndez Research Professor, Director of the Maternal, Child and Reproductive Health Initiative and Programme -
Jose Muñoz Associate Research Professor
Projects
Pre-Exposure Prophylaxis with Hydroxychloroquine for High-Risk Healthcare Workers during the COVID-19 Pandemic
A Unicentric, double-blinded, randomized controlled trial
SeroCov-1
A hospital-based seroprevalence study of SARS-CoV-2. Immunological dynamics within one-year period
COVID-PREG
Eficacia de hidroxicloroquina en la prevención de la infección por SARS-CoV-2 y de la gravedad de la enfermedad de COVID-19 durante el embarazo
SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT)
Pilot Study to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission
CORSAIR
Severe respiratory failure in COVID-19: clinical, biological and imaging risk factors
Encuesta serológica Cendea de Cizur
Cendea de Cizur
COVICAT
Cohorte Covid-19 en Cataluña
CoViproteHCt
Spatio-temporal analysis of COVID-19 cases to inform scaling down of confinement measures as well as reactive strategies onward
A modelling analysis